Mary L. Yost, MBA

Mississippi Delta Miracle: Angiographic Screening Yields Dramatic Reduction in Amputations

05/19/2020

Prior to the affiliation of a peripheral interventional cardiologist within BMC, the institution performed zero peripheral angiograms and 56 major amputations. In just a few short years, CVSCM facilitated an 87.5% decrease in the...

Prior to the affiliation of a...

05/19/2020

Cath Lab Digest

Interview

Why Are We Failing to Prevent Amputations?

09/21/2023

Mary L. Yost , MBA;

At the 2023 Amputation Prevention Symposium (AMP), Mary Yost, MBA, president of the Sage Group, the leading research and consulting company specializing in peripheral vascular disease, presented her thoughts on the reasons why clinicians are...

At the 2023 Amputation...

09/21/2023

Vascular Disease Management

Diabetes Watch

Essential Keys To Diagnosing And Treating PAD In Patients With Diabetes

11/17/2017

Mary L. Yost , MBA;

Frank J. Tursi , DPM, FACFAS;

Craig M. Walker , MD, FACC, FACP, FSCAI, FCCP;

Peripheral arterial disease (PAD) is an extremely prevalent, substantially underdiagnosed condition, which has a significant risk of morbidity and mortality.

Peripheral arterial disease...

11/17/2017

Podiatry Today

Original Research

The Current U.S. Prevalence of Peripheral Arterial Disease

04/20/2023

Mary L. Yost , MBA;

This study calculated a more accurate 2020 PAD prevalence employing the Diabetes Method and to compare PAD prevalence by this method with those of the Criqui/PARTNERS and Nehler methods for 1995 and for the 2010 to 2030 period.

This study calculated a more...

04/20/2023

Vascular Disease Management